Skip to contentC
Cerenome, Inc.
C
CNSYCerenome, Inc. Q1 2024 · 10-Q
Revenue$1.68M$1.68Mno prior Q1 2023 on file Net Income-$3.26M-$3.26MN/M vs Q1 2023 EPS Diluted-$0.75-$0.75N/M vs Q1 2023 Operating Income-$3,299,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
Free Cash Flowderived-$4,553,000N/M Margins · derivedOperating margin-196.7%
Net margin-194.5%
ended Mar 31, 2024 · filed May 15, 2024 · 45 d after period end